Indegene Ltd share price logo

Indegene Ltd Share Price

(INDGN)

₹570.150.82%

as on 04:01PM, 17 Apr 2025

bell
The current prices are delayed by 15 mins, login to check live prices.

Indegene Ltd Performance

  • Day's Low

    Day's High

    ₹567.35
    Day's Price Range
    ₹578.95
  • 52 Week's Low

    52 Week's High

    ₹470.1
    52-Week Price Range
    ₹736.3
1 Month Return+ 7.64 %
3 Month Return-15.38 %
1 Year Return-0.13 %
Previous Close₹574.85
Open₹570.10
Volume2.07L
Upper Circuit₹689.80
Lower Circuit₹459.90
Market Cap₹13,684.05Cr

Indegene Ltd Fundamentals

P/E Ratio

31.5

PEG Ratio

1.41

Market Cap

₹1,528.96 Cr

P/B Ratio

2.89

EPS

37.46

Dividend Yield

0.39

Sector

Healthcare

ROE

16.14

Indegene Ltd Analyst Rating

based on 5 analysts

HOLD

40.00%

Buy

40.00%

Hold

20.00%

Sell

Based on 5 analysts offering long term price targets for Indegene Ltd. An average target of ₹657

Source: S&P Global Market Intelligence

Indegene Ltd Share analysis

Indegene Ltd price forecast by 5 analysts

Upside of15.23%

High

₹800

Target

₹657.00

Low

₹495

Indegene Ltd target price ₹657, a slight upside of 15.23% compared to current price of ₹570.15. According to 5 analysts rating.

Source: S&P Global Market Intelligence

Key events for Indegene Ltd

  • Indegene Receives Positive Brokerage Rating Amid AI Growth - 27 Mar, 2025

    A brokerage firm maintains a BUY rating for Indegene, emphasizing its potential in AI-driven solutions for pharmaceutical commercialization. The company is well-positioned to benefit from digital transformation in the industry.
  • Indegene Subsidiary Acquires MJL Communications Group - 26 Mar, 2025

    Indegene Ltd's subsidiary, Indegene Ireland, plans to acquire MJL Communications Group and its subsidiary MJL Advertising for GBP 3.4 million, aiming for business expansion.
  • JPMorgan Maintains Neutral Rating on Indegene - 25 Mar, 2025

    JPMorgan has maintained a Neutral rating on Indegene with a target price of Rs 650. The brokerage emphasizes growth through client penetration, cross-selling, and a strong pipeline of new drug launches, despite potential revenue impacts from generative AI projects. Indegene's M&A strategy will focus on enhancing capabilities in commercial, regulatory, and medical affairs.
  • Indegene Expands European Operations with London Center - 20 Mar, 2025

    Indegene Limited is expanding its European presence by opening a new center in London, enhancing its consulting and commercialization capabilities. The company reported significant revenue from Europe and saw a 2% share price increase following the announcement.
  • Indegene Limited Reappoints Directors and Approves Share Allotment - 13 Mar, 2025

    Indegene Limited has reappointed three Independent Directors for a second five-year term, pending shareholder approval. The Board also approved equity share allotment under the RSU 2020 plan, enhancing governance and growth prospects.

Insights on Indegene Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 4.82% to 5.03% in Dec 2024 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 92.01% to 90.99% in Dec 2024 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, INDGN stock has moved down by -0.2%

Indegene Ltd Financials

Value in ₹ crore
DetailsQ'4 23Q'1 24Q'2 24Q'3 24Q'4 24
Revenue₹673.40Cr (-)₹673.00Cr (↓0.06%)₹676.50Cr (↑0.52%)₹686.80Cr (↑1.52%)₹720.40Cr (↑4.89%)
Net Income₹98.80Cr (-)₹94.80Cr (↓4.05%)₹87.70Cr (↓7.49%)₹91.70Cr (↑4.56%)₹109.70Cr (↑19.63%)
Net Profit Margin14.67% (-)14.09% (↓3.95%)12.96% (↓8.02%)13.35% (↑3.01%)15.23% (↑14.08%)
Value in ₹ crore
Details2021202220232024
Total Assets₹373.80Cr (-)₹852.10Cr (↑127.96%)₹1,039.10Cr (↑21.95%)₹1,222.80Cr (↑17.68%)
Total Liabilities₹119.90Cr (-)₹202.10Cr (↑68.56%)₹243.80Cr (↑20.63%)₹269.00Cr (↑10.34%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow₹89.60Cr (-)₹53.30Cr (↓40.51%)₹38.20Cr (↓28.33%)₹81.90Cr (↑114.40%)₹176.20Cr (↑115.14%)

Indegene Ltd Index Inclusions

Nifty Smallcap 250

₹15,452.10

0.45 (69.65%)

BSE Healthcare

₹41,697.12

0.91 (377.9%)

BSE IPO

₹13,630.70

1.41 (189.92%)

Nifty 500

₹21,681.55

1.3 (277.2%)

BSE Small-Cap

₹47,946.66

0.52 (248.31%)

Nifty MidSmallcap 400

₹18,008.90

0.54 (96.3%)

S&P BSE AllCap

₹10,471.31

0.68 (71.07%)

Indegene Ltd Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
0%
0.00
Foreign Institutions
5.03%
4.36
Mutual Funds
1.64%
-0.22
Retail Investors
90.99%
-1.11
Others
2.34%
53.07

Indegene Ltd Key Indicators

Details20202021202220232024
Return On Equity %67.4796.3629.3618.0215.77
Details20202021202220232024
Return On Assets %-1.4639.9719.3425.6127.54

Indegene Ltd Valuation

Indegene Ltd in the last 5 years

  • Overview

  • Trends

Lowest (30.56x)

February 27, 2025

Today (34.58x)

April 17, 2025

Industry (101.73x)

April 17, 2025

Highest (44.81x)

October 1, 2024

LowHigh

Indegene Ltd Earnings and Dividends

  • Indegene Ltd Earnings Results

    Indegene Ltd’s net profit jumped 11.03% since last year same period to ₹109.70Cr in the Q3 2024-2025. On a quarterly growth basis, Indegene Ltd has generated 19.63% jump in its net profits since last 3-months.

    Read More about Earnings Results

Indegene Ltd Technicals Summary

Bearish

Neutral

Bullish

Bullish

Indegene Ltd is currently in a Bullish trading position according to technical analysis indicators.

Indegene Ltd Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
NA₹1,528.96 Cr232.15%0.50₹32 Cr₹74 Cr
NA₹23.31 Cr10.19%0.93NANA
NA₹7.99 Cr50.27%0.58NANA
NA₹27.17 Cr-16.68%0.58NANA
NA₹66.50 Cr26.15%0.56-₹2 Cr₹39 Cr

About Indegene Ltd



Revenue: ₹720.40Cr as on December 2024 (Q4 24)
Net Profit: ₹109.70Cr as on December 2024 (Q4 24)
Listing date: 13 May, 2024
OrganisationIndegene Ltd
Headquarters
IndustryHealthcare
E-voting on sharesClick here to vote

FAQs on Indegene Ltd

What is Indegene Ltd price today?

Indegene Ltd share price today stands at ₹570.15, Open: ₹570.1, Previous Close: ₹574.85, High: ₹578.95, Low: ₹567.35, 52 Week High: ₹736.3, 52 Week Low: ₹470.1.

How to Buy Indegene Ltd Share in India?

  • Get a PAN card
  • Open a Demat account
  • Open a Trading account
  • Link your Demat account to your Trading account
  • Fund your Trading account
  • Place an order to buy Indegene Ltd shares

What are today's traded volumes of Indegene Ltd?

Today's traded volume of Indegene Ltd(INDGN) is 2.07L.

What is today's market capitalisation of Indegene Ltd?

Today's market capitalisation of Indegene Ltd(INDGN) is ₹13684.05Cr.

What is the 52 Week High and Low Range of Indegene Ltd?

Indegene Ltd (INDGN)
Price
52 Week High
₹736.3
52 Week Low
₹470.1

How much percentage Indegene Ltd is down from its 52 Week High?

Indegene Ltd (INDGN) share price is ₹570.15. It is down -22.57% from its 52 Week High price of ₹736.3

How much percentage Indegene Ltd is up from its 52 Week low?

Indegene Ltd (INDGN) share price is ₹570.15. It is up 21.28% from its 52 Week Low price of ₹470.1